Neuren Pharmaceuticals Ltd
ASX:NEU
Wall Street
Price Targets
NEU Price Targets Summary
Neuren Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for
NEU
is 25.22 AUD
with a low forecast of 21.41 AUD and a high forecast of 31.61 AUD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NEU's stock price target?
Price Target
25.22
AUD
According to Wall Street analysts, the average 1-year price target for
NEU
is 25.22 AUD
with a low forecast of 21.41 AUD and a high forecast of 31.61 AUD.
What is Neuren Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
-15%
For the last 13 years the
compound annual growth rate for
Neuren Pharmaceuticals Ltd's revenue is
38%.
The projected
CAGR
for the next 4 years is
-15%.
What is Neuren Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
31%
The
compound annual growth rate
of Neuren Pharmaceuticals Ltd's operating income for the next 4 years is
31%.
What is Neuren Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
28%
The
compound annual growth rate
of Neuren Pharmaceuticals Ltd's net income for the next 4 years is
28%.
